Cilostazol 50 mg used for
Web建立西洛他唑分散片有关物质的检测方法.采用C8柱(250 mm×4.6 mm,5μm);流动相A为乙腈-水(25∶75),流动相B为乙腈-水(50∶50);梯度洗脱:0-6 min-10 min-40 min,流动相A∶B的比例为100∶0-50∶50-0∶100-0∶100;检测波长254 nm.结果表明,西洛他唑与各已知杂 … WebMay 30, 2024 · Cilostazol occurs as white to off-white crystals or as a crystalline powder that is slightly soluble in methanol and ethanol, and is practically insoluble in water, 0.1 N HCl, and 0.1 N NaOH.. PLETAL …
Cilostazol 50 mg used for
Did you know?
Web25-200 mg cilostazol tab 50 mg, 100 mg clopidogrel bisulfate tab 75 mg (Plavix), 300 mg (base equivalent) dipyridamole tab 25 mg, 50 mg, 75 mg prasugrel hcl tab 5 mg, 10 mg (base equivalent) (Effient) warfarin sodium tab 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, susp 150 mg/mL (Depo7.5 mg, 10 mg Bowel Preparation WebSep 27, 2024 · Cilostazol (Pletal) received an overall rating of 7 out of 10 stars from 4 reviews. See what others have said about Cilostazol (Pletal), including the effectiveness, ease of use and side effects. ... This is a strong med so my doctor started me off on 50 mg twice a day for one week. Then I went to 100mg twice a day. Well what I did was to wake ...
WebJul 10, 2024 · Background and Purpose: Cilostazol, a phosphodiesterase 3’ inhibitor, is used in Asia-Pacific countries for stroke prevention, but rarely used elsewhere. In addition to weak antiplatelet effects, i... Cilostazol … WebSep 10, 2024 · Cilostazol is a quinolinone derivative used for treatment of intermittent claudication and peripheral vascular disease. Learn about side effects, drug interactions, …
WebSep 21, 2024 · Cilostazol is a quinolone derivative primarily used to treat intermittent claudication due to peripheral vascular disease, the FDA-approved indication. Cilostazol … WebOct 12, 2024 · fever, chills, sore throat, mouth sores; or. easy bruising, unusual bleeding, purple or red spots under your skin. Common side effects may include: …
WebReduce Pletal dose to 50 mg twice daily when coadministered with strong or moderate inhibitors of CYP2C19. Summary Pletal (cilostazol) is a quinolinone derivative used to treat intermittent claudication, a condition caused by narrowing of the …
WebApr 1, 2024 · Descriptions. Cilostazol improves the flow of blood through the blood vessels. It is used to reduce leg pain caused by poor circulation (intermittent claudication). … prawn peeler youtubeWebAs noted, avoidor use with caution. Cilostazol: lowNondihydropyridineCCBs: moderateNSAIDs: moderateCOX-2 inhibitors: lowThiazolidinediones: highDronedarone: high ... Reduce dose if CrCl 15-50 mL/min Avoid if CrCl < or >95 mL/min. Moderate Strong. ... Doxepin (>6 mg) Darifenacin Imipramine Fesoterodine Nortriptyline Flavoxate Paroxetine ... prawn perks rs3Webswelling in the legs or ankles. Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome): … prawn perk points rs3WebMar 9, 2024 · Cilostazol 50 mg tablets - Summary of Product Characteristics (SmPC) - (emc) Cilostazol 50 mg tablets Active Ingredient: cilostazol Company: Mylan See contact details ATC code: B01AC23 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) This information is for use by healthcare … scientific lenses for kidsWebCilostazol is used in the treatment of intermittent claudication. It helps in reducing the symptoms of intermittent claudication like pain, cramping, numbness, or weakness in the legs that occurs on walking. How Cilostazol works prawn patties recipeWebTherefore, a dose of 50 mg twice daily should be considered when drugs that may increase the concentration of cilostazol also are being used. Combining pletal with other drugs … scientific lens historyWebSep 10, 2024 · Cilostazol is a quinolinone derivative used for treatment of intermittent claudication and peripheral vascular disease. Cilostazol is available under the following different brand names: Pletal. What Are Dosages of Cilostazol? Dosages of Cilostazol: Dosage Forms and Strengths Tablet 59 mg 100 mg Dosage Considerations – Should be … scientific letter to the editor